Artigo Acesso aberto

Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extract Library

2023; American Chemical Society; Volume: 9; Issue: 6 Linguagem: Inglês

10.1021/acsinfecdis.3c00067

ISSN

2373-8227

Autores

Lucero Martínez-Fructuoso, S J Ryan Arends, Vítor F. Freire, Jason R. Evans, Sean DeVries, Brian D. Peyser, Rhone K. Akee, Christopher C. Thornburg, Rohitesh Kumar, Susan M. Ensel, Gina Morgan, Grant D. McConachie, Nathan Veeder, Leonard R Duncan, Tanja Grkovic, Barry R. O’Keefe,

Tópico(s)

Bacterial Identification and Susceptibility Testing

Resumo

The continuing emergence of antibiotic-resistant microbes highlights the need for the identification of new chemotypes with antimicrobial activity. One of the most prolific sources of antimicrobial molecules has been the systematic screening of natural product samples. The National Institute of Allergy and Infectious Diseases and the National Cancer Institute here report a large screen of 326,656 partially purified natural product fractions against a panel of four microbial pathogens, resulting in the identification of >3000 fractions with antifungal and/or antibacterial activity. A small sample of these active fractions was further purified and the chemical structures responsible for the antimicrobial activity were elucidated. The proof-of-concept study identified many different chemotypes, several of which have not previously been reported to have antimicrobial activity. The results show that there remain many unidentified antibiotic compounds from nature.

Referência(s)